Sort   by:  
 Page size 
UnknownHigh-dose pharmaceutical-grade biotin in patients with demyelinating neuropathies: a phase 2b open label, uncontrolled, pilot study.
Not available
S-EPMC10614347 | biostudies-literature
UnknownResults from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial.
Not available
S-EPMC4562538 | biostudies-literature
UnknownClofarabine versus fludarabine-based reduced-intensity conditioning regimen prior to allogeneic transplantation in adults with AML/MDS.
Not available
S-EPMC5119961 | biostudies-literature
UnknownCurative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial.
Not available
S-EPMC5421327 | biostudies-literature
UnknownPIK3R1 mutations cause syndromic insulin resistance with lipoatrophy.
Not available
S-EPMC3710759 | biostudies-literature
Unknown<i>PFMG2025</i>-integrating genomic medicine into the national healthcare system in France.
Not available
S-EPMC11910791 | biostudies-literature
Sort   by:  
 Page size